Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for Cognitive Deficits Post Low Grade Glioma Surgery
NCT02122042Phase 1Unknown
- Sponsor
- Shamir Medical Center
- Start
- May 2014
- Primary completion
- May 2017
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Shamir Medical Center. Primary endpoint: Neurocognitive functions at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT02122042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122042.